Six Drugs Selected to Advance in EMA's Adaptive Pathways Pilot Program
By Michael Mezher -
Published 13 January 2015
The European Medicines Agency (EMA) recently announced that it has selected six drugs to move forward in its adaptive pathways (formerly adaptive licensing) pilot program.
Categories: News, Europe, EMA, Biologics and biotechnology, Clinical, Drugs, Postmarket surveillance, Submission and registration
Tags: Adaptive Pathway, Adaptive Licensing, Adaptive Pathways Pilot Program